J&J To Appeal $37M Mesothelioma Verdict, A First In Talc Trials
This article was originally published in The Rose Sheet
Executive Summary
The mesothelioma liability case marks the first in New Jersey, the first involving a male plaintiff and the first to result in a plaintiff verdict. Punitive damages, potentially on top of the $37m in compensatory damages, have yet to be decided in the matter linking J&J’s talc to asbestos dangers.
You may also be interested in...
FDA-Proposed Talc Testing Methods Likely Would Find Particles Of Concern; Then What?
The FDA is focused on driving adoption of more sensitive, standardized testing methods for assessing cosmetic talc purity, which it believes would yield more consistent results across labs. This would help to inform research into the health implications of trace levels of asbestos and other elongate mineral particles in talc; in the interim it could to be damaging to companies that supply or use that talc.
Overwhelmed J&J Talc Supplier Takes Cover Under Bankruptcy Protections
“It is simply not in the best interests of our stakeholders to litigate these claims in perpetuity,” says Imerys Talc America President Giorgio La Motta of the company’s decision to reorganize its business and debts under Chapter 11 in negotiation with claimants in cosmetic talc-related suits.
J&J Doing Damage Control Following Reuters Report On Asbestos ‘Lurking’ In Johnson’s Powder
J&J shares are down nearly 12% since Reuters reported Dec. 14 that the firm has known for decades about toxic asbestos in its Johnson’s Baby Powder talc. The news outlet’s probe turned up nothing that hasn’t been raised by plaintiff attorneys, but throws the central issues of contention into high relief for its global audience.